CDT
CDT Equity Inc.
NASDAQ · USHealthcareBiotechnology
$3.56+13.75%
Price as of Jul 20, 2026
CDT profitability
CDT Equity Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 37.1%
- EBITDA margin
- 11.3%
- EBIT margin
- 6.4%
- Net margin
- 2.4%
- Free cash flow margin
- -0.9%
Returns
- Return on equity
- 1.3%
- Return on assets
- 0.5%
- Return on invested capital
- 1.7%
- Asset turnover
- 0.20x
Cash efficiency
- Cash from operations
- $79.1M
- Cash per share
- $56
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.